Thursday August 13, 2020 0 comments
BOULDER -- Biodesix, Inc. announced it will provide COVID-19 ddPCR diagnostic testing for Colorado State University as students return to campus for the fall term, which begins Aug. 24.
“The health and safety of our nation’s students, and the faculty and staff that teach, guide, and mentor them, is of utmost importance to us,” said Scott Hutton, CEO of Biodesix.
“We are pleased to be able to support CSU in their efforts to help navigate a return to campus during this global pandemic. We understand that timely results are critical, and are proud that our tests with their rapid time to results are a part of this important plan.”
The Biodesix SARS-CoV-2 ddPCR Test, which was released in partnership with Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), detects SARS-CoV-2 (the virus that causes COVID-19) and earned Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration earlier this year.
Since April, Biodesix has processed more than 40,000 tests with results delivered in 24-48 hours.